News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug


10/7/2011 7:16:47 AM

Takeda Pharmaceutical said on Friday it would discontinue development of insomnia drug ramelteon in Europe, after feedback on development requirements from the region's regulatory body. The drug, available as Rozerem in the United States and Japan, was once seen as a promising source of income for the Japanese firm, but sales never took off as expected because some patients found its effects were not as strong or immediate as desired.



comments powered by Disqus
   
Insomnia

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES